| abstract |
This is related to a solid pharmaceutical composition for preventing or treating cardiovascular disorders comprising amlodipine or a pharmaceutically acceptable salt thereof and losartan or a pharmaceutically acceptable salt thereof, which exhibits high dissolution rates of amlodipine and losartan even under conditions of Low pH and improved storage stability. Claim 2: The composition of claim 1, characterized in that the amlodipine or the pharmaceutically acceptable salt thereof and losartan or the pharmaceutically acceptable salt thereof are separated from each other. Claim 10: The composition of claim 1, characterized in that the pharmaceutically acceptable salt of amlodipine is amlodipine camsylate. |